Editor’s Pick
- 
    Current challenges for investorsRoger MontgomeryMay 30, 2017In this week’s video insight Roger discusses the current challenges for investors, particularly those focused on quality and opportunities for growth. This being due to reasons such as the expected downturn in the property market, inevitable downturn in construction activity and record levels of debt. by Roger Montgomery Posted in Editor's Pick, Video Insights.
- 
      Chinese investment in Australian property takes a diveRoger MontgomeryMay 30, 2017For some time, property advocates have been arguing that Australian residential real estate prices will remain buoyed by the steady stream of Chinese immigrants buying property at any price. Now, it seems, that stream is turning to a trickle as the impact of tighter credit starts to bite. continue… by Roger Montgomery Posted in Editor's Pick, Property.- 2 Comments
- save this article
- POSTED IN Editor's Pick, Property
 
- 
      MEDIA Buy Hold Sell: Where is the value?Roger MontgomeryMay 25, 2017Roger Montgomery featured in Livewire’s Buy Hold Sell to discuss the stocks that are hitting 12 month lows. Watch the 3 minute clip below. by Roger Montgomery Posted in Editor's Pick, TV Appearances.
- save this article
- POSTED IN Editor's Pick, TV Appearances
 
- 
      After its price dip, is Telstra now good value?Tim KelleyMay 24, 2017  Telstra (TLS) is not high on the list of businesses we would most like to own. Having said that, it is not a terrible business, and at the right price it makes sense to own it, particularly given its steady dividend stream. So, with TLS’s share price down around 20 percent over the past year, we decided to assess its value. continue… by Tim Kelley Posted in Companies, Editor's Pick.- 14 Comments
- save this article
- POSTED IN Companies, Editor's Pick
 
- 
      Index funds lack checks on stocks they buyRoger MontgomeryMay 15, 2017If you’re an educated investor, should you be investing in index funds? We don’t believe so. And the reason is simple: index funds are not selective in their approach to buying and selling stocks, and ignore the long-term drivers of returns, such as ‘value’ and ‘quality’. continue…by Roger Montgomery Posted in Editor's Pick, Investing Education.
- 
      Why we continue to hold Vita GroupScott ShuttleworthMay 15, 2017Vita Group Limited (ASX: VTG) released an announcement that spooked the market, but was the news really that bad or did the market over-react? In this post we cover the main points of the announcement. continue… by Scott Shuttleworth Posted in Companies, Editor's Pick, Technology & Telecommunications.
- 
    Are banks and resources starting to roll over?Roger MontgomeryMay 9, 2017In this week’s video insight Roger discusses the outlook for banks, retailers and resource companies. He also discusses the recent performance of Montgomery’s domestic and global funds. by Roger Montgomery Posted in Editor's Pick, Video Insights.
- 
      Why residential real estate is a poor investment right nowRoger MontgomeryMay 2, 2017Have you ever wondered why Australia has no listed residential REITs (real estate investment trusts)? The simple answer is that they would offer poor returns. And, these days, the returns would be worse than ever. But the good news for would-be buyers is that the property price bubble could be about to end. continue… by Roger Montgomery Posted in Editor's Pick, Property.- 6 Comments
- save this article
- POSTED IN Editor's Pick, Property
 
- 
      Is it time to hold more cash?Roger MontgomeryMay 1, 2017Warren Buffett once wrote that “cash is a bad investment over time. But you always want to have enough so that nobody else can determine your future.” We agree. And with most investors having migrated away from cash, we see some good reasons why holding more looks like a good idea right now. continue…by Roger Montgomery Posted in Editor's Pick, Market commentary.
- 
      The news looks good, so why have Sirtex shares been dumped?Scott ShuttleworthApril 25, 2017Over the weekend, the results were released of a trial comparing the efficacy of two treatments for late stage liver cancer. The treatments were SIRT, pioneered by Australian biotech, Sirtex, versus Sorafenib. The results were generally positive for SIRT. So why has the market responded so harshly? 
 continue…by Scott Shuttleworth Posted in Editor's Pick, Health Care.- 6 Comments
- save this article
- POSTED IN Editor's Pick, Health Care
 



 
				                                













